The current research & development by business enterprise, pharmaceutical industry in current ppp $ of Poland is 298.08 million, an increase of 90.41 million (43.5%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Poland
No matching regions
Similar regions to Poland
Business R&D pharmaceutical in current PPP $
More indicators for Poland
Government R&D in security as % of government support
4.13%
+0.82%
(2021)
Higher-education-finacing R&D financed by general university in local currency
60,574.85M
+13,304.51M
(2021)
R&D financed by rest of the world in local currency
30,791.22M
+7,537.32M
(2021)
Government R&D financed by rest of the world in local currency
938.25M
+346.95M
(2021)
Business R&D financed by rest of the world in local currency
18,960.22M
+4,066.30M
(2021)
Non-profit R&D growth rate
1.18%
+8.51%
(2022)
Poland Business R&D pharmaceutical in current PPP $ between 2005 and 2021
Period | Business R&D pharmaceutical in current PPP $ | Change |
---|---|---|
2021 | 298.08M | +90.41M |
2020 | 207.67M | -66.37M |
2019 | 274.04M | -29.39M |
2018 | 303.43M | +40.65M |
2017 | 262.78M | +82.91M |
2016 | 179.88M | -36.03M |
2015 | 215.91M | +65.21M |
2014 | 150.70M | +27.88M |
2013 | 122.81M | -21.33M |
2012 | 144.14M | +51.27M |
2011 | 92.87M | +6.84M |
2010 | 86.03M | +0.86M |
2009 | 85.17M | -16.01M |
2008 | 101.18M | +34.12M |
2007 | 67.06M | +0.97M |
2006 | 66.09M | -4.91M |
2005 | 71.00M |